| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of Rare Disease | Chief Commercial Officer
1 company
Mutz Christopher is a Head Of Rare Disease at ANI Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $7.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | ANIP Ani Pharmaceuticals, Inc. | Head Of Rare Disease | Sell | 3,162 | $71.64 | $226,525.68 | -3.3% | - | - | |
| May 14, 2025 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 4,000 | $60.45 | $241,800.00 | -3.6% | +46.3% | - | |
| Nov 15, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 6,500 | $57.70 | $375,050.00 | -7.8% | +4.6% | +48.5% | |
| May 21, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 2,000 | $61.61 | $123,220.00 | -2.3% | -0.8% | -4.3% | |
| Mar 5, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 5,000 | $66.00 | $330,000.00 | -5.4% | -2.9% | -8.7% | |
| Nov 10, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of Rare Disease | Sell | 3,000 | $52.47 | $157,410.00 | -4.5% | +7.2% | +17.8% |